Attorneys Aim to Reform “Compassionate Use”

E-ISSN： 1097-0142|121|2|163-164

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.2, 2015-01, pp. : 163-164

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cabazitaxel + prednisone: compassionate-use safety findings

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme

By Rayner C.R.

Clinical Pharmacokinetics, Vol. 42, Iss. 15, 2003-01 ,pp. : 1411-1423

Adis International

Access to resources Recommend Favorite

EU Compassionate Use Programmes (CUPs): Regulatory Framework and Points to Consider before CUP Implementation

By Sou Hélène

Pharmaceutical Medicine, Vol. 24, Iss. 4, 2010-08 ,pp. : 223-229

Adis International

Access to resources Recommend Favorite

5% Lidocaine Medicated Plaster in Elderly Patients with Postherpetic Neuralgia: Results of a Compassionate Use Programme in France

By Clère Florentin

Drugs & Aging, Vol. 28, Iss. 9, 2011-09 ,pp. : 693-702

Adis International

Access to resources Recommend Favorite

CVS, FDA aim to reduce tobacco use: The drugstore chain and the FDA step up antismoking efforts

By Printz Carrie

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1597-1598

Blackwell Publishing

Access to resources Recommend Favorite